Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Flaxseed vs. Aromatase Inhibitors: Breast Tumor Characteristics and Prognosis

NCT00612560 is registered in ClinicalTrials.gov with Roswell Park Cancer Institute as lead sponsor.

NCT NCT00612560
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00612560 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Flaxseed vs. Aromatase Inhibitors: Breast Tumor Characteristics and Prognosis
Lead sponsor
Roswell Park Cancer Institute
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2007
Completion date
April 30, 2014
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer